Estos resultados concuerdan con el estudio de Burr et al (4), en el que la mayoria de FCTL se clasificaron como de alto grado y de origen de celulas B.
Concluimos que la quimioterapia antineoplasica con lomustina no fue eficaz en este caso de FCTL debido a la progresion de la enfermedad.
Feline cutaneous tarsal lymphoma (FCTL) corresponds to an uncommon manifestation presented as a subcutaneous mass located in the tarsal region (4).
Feline cutaneous lymphoma has been described as non-epitheliotropic and predominantly of T-cell origin; however, descriptions of FCTL suggest that this form is non-epitheliotropic, high-grade and of B-cell origin in the majority of cases (24).
The aim of this study was to report the first case of FCTL in Brazil and to describe the clinical signs, diagnostic procedure and therapeutic effect using lomustine and prednisolone of this rare and aggressive form of cutaneous lymphoma in cats.
These findings are in agreement with the study by Burr et al (4), in which the majority of FCTL was classified as high-grade and of B-cell origin.
We concluded that antineoplastic chemotherapy with lomustine was not effective in this case of FCTL due to disease progression.
Medial aspect of right hind limb of a 13-years-old, male, Domestic Longhair cat with FCTL. A subcutaneous and ulcerated mass is located in the tarsus.
FCTL noted that it will continue its business of designing and building custom solid oxide fuel cell (SOFC) power systems and will act as a reporting issuer under applicable securities legislation in Ontario.
Contact: Vikram Varma, FCTL, phone 613-541-6109, website http://www.fct.ca.